Lantheus Holdings Inc at Barclays Global Healthcare Conference Transcript
Morning, everybody. My name is Luke Sergott, I cover life science tools here at Barclays. It's my pleasure to have Mary Anne Heino from Lantheus Holdings, which she's going to give us an update in our presentation today.
Thank you, Luke, and good morning, everyone. As Luke said, I'm Mary Anne Heino, I am President and Chief Executive Officer of Lantheus. I will warn you, I have a lot of material here today, so I'll move through some of it quickly, so we can get some questions if we have them.
The first thing I have to show is the safe harbor statement. So please, this is also available on our website. Please take a moment to read it there, but this says you should very much interpret what I say as my opinion and the opinion of the company and not necessarily a reason to invest, although I do think it's a great idea. So why don't we get into the presentation.
For those of you who are not aware,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |